Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
eNq1mNty2jAQhu95Co8veodtTgFaG6alSctMMqUkTDu9YYS9BFEjOTpw6NNXxqQhHblJBbq0Zf+70q4+/aOwv12lzhoYx5REbs0LXAdITBNM7iN3cndV7bj9XiVcojU6+qztBV6t7jpxijiP3HzUmwEi3Pt+c/0R1P/A3F7FCelsCbF49p0UOPU+I764QVn+jROuKU6cFYgFTSI3k2L/1gm5YCqL3oaynzxDMYT+4c3x6HLaPH4f+rnYK1QlB3aNyL1WFIiRZiwZAyIGSMA9ZbuSfBtG2piPgVPJYhghsRgxusYJJNoQc5RyMAoy3yS3wNYpiDyIVtxfxituJI6WaDuGh6E+6fdqdCC2ohpUa+2LZrvbbLaCoH5hFIodLZW+CmoSfjytNVrddiPwgShlNaKKZ1icEWUCpZbKgvngeWdZisPg4cXyJ5hnKdp5S56ZLhViSA0DU/vf3kTyGdwxRaRUrdlf+kSmqf+fWU8OvLCUcY6jAZVElGDjamy6EANKBGzLK2pGOrE99CIGfj7ZX5ToKT+SsxTHpkxT1JHAxWQ8LEfaWWnwAXGYMHs4+IZJQjf8/Jg5Lqul7LM9KbWiGUtq03q3c1FrtYx30Q/VQyVnzKVkNANfAQjzU7gyJHN6KlFUW+qlHpvyfP24tzo0RimUmJ2qIV1UIz56M2utbm8bFQNa0U+Xd6b98VUC293uH7XSOIn+VNYMvTZ4rrrxpcSLfRtl00bQ6nQbzTdolb17dNGRoWMuRK0YZsn0kFkIkfG3vr9AvMqRWktvzv5xAvS18z7H3BVun0ppz9BbOf8LP1Sg1lLqs+IMfX0NTXfsS+7gVMd7+P/grLUxBJNwQh0KuFtD8PDy/FR/srvW0h49Y4u9MHtrigSmxJZjkjOt4mnniKoruWIKDl/mc1xyuVLal6FfXOz0KqGfX+r0Kr8Bynz/XA==
McShKXpse6CKcU7A
Listen
